Later school start times are being considered to address youth mental health crises; states are taking action to enact legislation on opioid addiction and fentanyl-related deaths; Unilever recalls 2 Suave aerosol antiperspirant products due to a potential carcinogen.
ABC News is reporting that several states are considering later school start times as a way to promote healthy sleep habits among children and teens and to address growing pandemic-related mental health concerns. Experts say that school start times of 8:30 am or later would better align with adolescents’ biological sleep rhythms and would promote optimal sleep. Moreover, prior research has shown that in high schools with start times of 8:30 am or later, student sleep time, academic outcomes, and attendance rates all improved, and car crashes involving teen drivers decreased.
State lawmakers are considering the adoption of laws to address the opioid epidemic, specifically fentanyl-related deaths, as drug overdoses linked with synthethic opioids continue to climb nationwide. The Associated Press is reporting that potential laws would work to reduce the risk of overdose to users and increase the penalties for those dealing fentanyl or mixing it with other drugs. Bills to legalize test strips that detect the presence of fentanyl have been passed in New Mexico’s and West Virginia’s legislation, and they now await final approval from the states' governors.
Unilever announced that it is recalling 2 Suave aerosol antiperspirant products due to the presence of elevated benzene levels found in some samples during an internal review. NPR is reporting that the recalled lots of 2 antiperspirants with expiration dates through September 2023 include Suave 24-Hour Protection Aerosol Antiperspirant Powder in 4 ounce and 6 ounce sizes and Suave 24-Hour Protection Aerosol Antiperspirant Fresh in the 6 ounce size. Exposure to benzene through inhalation, an oral route, and the skin has been associated with an increased risk of leukemia and other blood cancers.
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More